<b>Objective</b>: This study investigates the prognostic value and clinical utility of the neutrophil percentage-to-albumin ratio (NPAR) in patients with resected non-small-cell lung cancer (NSCLC). This evidence concerns the gene ALB and non-small cell lung carcinoma.